Noelia Montoya

Noelia Montoya

Auto-generated profile, based on publicly available information

Noelia Montoya

Neurotraumatology and Neurosurgery Research Unit (UNINN), Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona , Barcelona, Spain

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2005 in Autonomic & Autacoid Pharmacology
Verified
Journal Article
Closed access
PDF file
ABA. M. Briones
A. M. Briones
NMN. Montoya
N. Montoya
JGJ. Giraldo
J. Giraldo
EVE. Vila
E. Vila

1 January 2015 in Journal of Neurotrauma
Verified
Journal Article
Closed access
TMTamara Martínez-Valverde
Tamara Martínez-Valverde
MVMarian Vidal-Jorge
Marian Vidal-Jorge
NMNoelia Montoya
Noelia Montoya
ASAngela Sánchez-Guerrero
Angela Sánchez-Guerrero
SMSusana Manrique
Susana Manrique
JSJuan Sahuquillo
Juan Sahuquillo
Our aim is to determine whether the ionic concentration in brain microdialysate enables calculations of the actual Na(+), K(+), and Cl(-) concentrations in vitro and whether this method can be applied to determine the ionic concentrations in the brain extracellular fluid. We designed an experiment using CMA-71 probes (M Dialysis, Stockholm, Sweden) and the standard conditions used in a clinical setting. Nine CMA-71 probes were inserted in different matrices and perfused with mock cerebrospinal fluid containing 3% albumin at the standard infusion rate used in the clinical setting (0.3 μL/min). Microvials were replaced every 12 h, and the ionic concentrations, both in the dialysate and the matrix, were analyzed. For each ion, scatter plots were built, with [Na(+)], [K(+)], and [Cl(-)] in the dialysate as the predictor variables and the matrix concentrations as the outcome variables. A linear regression model allowed us to calculate the true ionic concentrations in the matrix. To demonstrate the feasibility of the method, we present the calculated ionic profile of one patient with a malignant infarction and a second with a severe traumatic brain injury. Our results confirm that the ionic concentration in microdialysate can be used to calculate the true concentrations of ions in a matrix and the actual concentrations in the extracellular fluid. Microdialysis offers the unique possibility of monitoring the dynamic changes of ions in the brain over time and opens a new avenue to explore the brain's ionic profile, its changes in brain edema, and how this profile can be modified with different therapies.

14 December 2018 in Journal of Neurotrauma
Verified
Journal Article
Closed access
LCLidia Castro
Lidia Castro
MNMontoya Noelia
Montoya Noelia
MVMarian Vidal-Jorge
Marian Vidal-Jorge
DSDavid Sánchez-Ortiz
David Sánchez-Ortiz
DGDarío Gándara
Darío Gándara
JSJuan Sahuquillo
Juan Sahuquillo
Brain contusions (BCs) are one of the most frequent lesions in patients with moderate and severe traumatic brain injury (TBI). BCs increase their volume due to peri-lesional edema formation and/or hemorrhagic transformation. This may have deleterious consequences and its mechanisms are still poorly understood. We previously identified de novo upregulation sulfonylurea receptor (SUR) 1, the regulatory subunit of adenosine triphosphate (ATP)-sensitive potassium (K ATP ) channels and other channels, in human BCs. Our aim here was to study the expression of the pore-forming subunit of K ATP , Kir6.2, in human BCs, and identify its localization in different cell types. Protein levels of Kir6.2 were detected by western blot (WB) from 33 contusion specimens obtained from 32 TBI patients aged 14–74 years. The evaluation of Kir6.2 expression in different cell types was performed by immunofluorescence in 29 contusion samples obtained from 28 patients with a median age of 42 years. Control samples were obtained from limited brain resections performed to access extra-axial skull base tumors or intraventricular lesions. Contusion specimens showed an increase of Kir6.2 expression in comparison with controls. Regarding cellular location of Kir6.2, there was no expression of this channel subunit in blood vessels, either in control samples or in contusions. The expression of Kir6.2 in neurons and microglia was also analyzed, but the observed differences were not statistically significant. However, a significant increase of Kir6.2 was found in glial fibrillary acidic protein (GFAP)-positive cells in contusion specimens. Our data suggest that further research on SUR1-regulated ionic channels may lead to a better understanding of key mechanisms involved in the pathogenesis of BCs, and may identify novel targeted therapeutic strategies.